Firstly, the difference in the primary outcome of survival without local recurrence between TARGIT-IORT and EBRT was not significant for any of the tumour subgroups viz pathological tumour size, grade, ER status, PgR status, HER2 status and lymph node status (Table 1 and Fig. 1). The gene discussed is PGR; the disease is neoplasm.